MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,751 | -99.8% | 324,600 | +12.5% | 0.01% | +71.4% |
| Q3 2022 | $5,181,000 | +49.5% | 288,500 | +3.5% | 0.01% | +75.0% |
| Q2 2022 | $3,465,000 | +17.6% | 278,800 | +26.0% | 0.00% | +33.3% |
| Q1 2022 | $2,946,000 | +21.5% | 221,200 | +42.1% | 0.00% | 0.0% |
| Q4 2021 | $2,424,000 | -56.2% | 155,700 | -36.9% | 0.00% | -57.1% |
| Q3 2021 | $5,534,000 | +7.1% | 246,600 | +8.6% | 0.01% | +16.7% |
| Q2 2021 | $5,169,000 | +67.6% | 226,996 | +103.2% | 0.01% | +100.0% |
| Q4 2020 | $3,085,000 | +4.1% | 111,700 | -47.0% | 0.00% | 0.0% |
| Q3 2020 | $2,963,000 | -74.8% | 210,900 | -63.0% | 0.00% | -70.0% |
| Q2 2020 | $11,738,000 | +5309.2% | 569,266 | +1883.5% | 0.01% | – |
| Q1 2020 | $217,000 | +17.9% | 28,700 | +41.4% | 0.00% | – |
| Q2 2019 | $184,000 | -38.0% | 20,300 | +56.2% | 0.00% | – |
| Q2 2018 | $297,000 | -22.5% | 13,000 | -47.5% | 0.00% | – |
| Q3 2017 | $383,000 | +22.4% | 24,759 | -7.3% | 0.00% | – |
| Q2 2017 | $313,000 | – | 26,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 85,000 | $1,132,000 | 1.20% |
| Bellevue Group AG | 5,859,039 | $78,042,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $533,000 | 0.64% |
| Pier Capital, LLC | 294,954 | $3,929,000 | 0.50% |
| Resolute Capital Asset Partners LLC | 50,000 | $666,000 | 0.42% |
| Rhenman & Partners Asset Management AB | 249,300 | $3,321,000 | 0.33% |
| Hennion & Walsh Asset Management, Inc. | 409,079 | $5,449,000 | 0.29% |
| TORRAY INVESTMENT PARTNERS LLC | 79,868 | $1,064,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 195,211 | $2,600,000 | 0.08% |
| DUALITY ADVISERS, LP | 54,164 | $721,000 | 0.08% |